Who is this course for?
People interested in learning to deliver psychedelic-assisted therapy, including those looking to understand psychedelic practice and research.
The Certificate in Psychedelic-Assisted Therapies and Research is a comprehensive program designed to provide students with a thorough understanding of the therapeutic potential of psychedelics and make them eligible to participate in clinical trials as therapists
The Certificate in Psychedelic-Assisted Therapies and Research is a comprehensive program designed to provide students with a thorough understanding of the therapeutic potential of psychedelics and make them eligible to participate in clinical trials as therapists. The course covers a wide range of topics, including the history of psychedelic use in medicine, current research on the safety and efficacy of psychedelics in treating mental health conditions, and the ethical and legal considerations surrounding their use.
Throughout the program, students will learn from leading experts in the field, including researchers, clinicians, and policymakers. The course will also include hands-on training in the administration and facilitation of psychedelic-assisted therapies, as well as the design and implementation of research studies.
Upon completion of the program, students will have the knowledge and skills necessary to safely and effectively integrate psychedelic-assisted therapies into their professional practice and contribute to the ongoing research in this field.
This course is intended for healthcare professionals, researchers, and individuals who are interested in learning about the use of psychedelics in therapy and research. It's a part-time course which can be completed in 12 months.
People interested in learning to deliver psychedelic-assisted therapy, including those looking to understand psychedelic practice and research.
UK psychedelic and CNS trial infrastructure provider with specialist trial sites, sponsor-facing psychiatric research support, recruitment pathways, and therapist-related trial expertise.
View all Clerkenwell Health coursesPeople interested in learning to deliver psychedelic-assisted therapy, including those looking to understand psychedelic practice and research.
Format: Hybrid. Time commitment: 30 HOURS.
The listed price is $2,000. Confirm the latest tuition, fees, and payment options on the provider website.
The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.
The current listing status is Active. Use the provider website for the latest enrollment status.
By CIIS
Same course category
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass
Dates not announced
Source lists: Estimated 145 hours
Delivery: San Francisco, United States + Online + Portland, United States
By Clinical Cognitive Facilitator Training
Same course category
The Psilocybin Facilitator Training from the ‘Clinical Cognitive Facilitator Training’ is one of the accepted programs for the Oregon Facilitation Program, but currently their site doesn’t connect nor any other information about their course can be found.
Dates not announced
Delivery: Online + Beaverton, United States
Includes medicine self-experience
By AAA Learning Institute
Same course category
Standard Facilitator Program is a 162-hour Oregon facilitator training with both live online and self-paced online components. It covers psilocybin history, pharmacology, facilitation skills, group work, cultural equity, ethics, and safety.
Dates not announced